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Abstract 
Introduction: Granulomatous inflammation has been associated with malignancies such as breast, testicular, renal cell, and 
lymphoma. The coexistence of granulomatous inflammation in mediastinal/hilar lymph node with primary lung malignancy has 
been described in case reports. 
Our goal was to examine the frequency of granulomatous reaction in mediastinal/hilar lymph node in the patients who had un-
dergone surgical resection of lung cancer. 
Material and methods: We performed a retrospective analysis of 40 patients (1) aged ≥ 18 years and (2) who underwent lo-
bectomy or pneumonectomy from August 1, 2012 to October 31, 2016 at Saint Louis University Hospital and (3) had pathology 
suggestive of cancer.
Results: Of those 40 patients, 3 (7.5%) had granulomatous inflammation in the lymph nodes. None of these 3 individuals had 
evidence of metastasis in the particular lymph nodes with granulomatous inflammation. 
Conclusion: Our small cohort revealed that the presence of granulomatous inflammation in a lymph node can be safely taken as an 
evidence of the absence of metastasis to the lymph node. This finding can obviate the need for further sampling for the particular 
lymph node with granulomatous inflammation and can decrease the sampling time. 
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Introduction
Granulomatous inflammation has been asso-
ciated with breast and testicular malignancies, 
renal cell cancer, and lymphoma [1–3]. Additio-
nally, historical studies have shown an increased 
risk of cancer in patients previously diagnosed 
with sarcoidosis, especially lung cancer and 
lymphoma [4]. This association had previously 
been termed sarcoid-like reaction and sarcoid 
cancer syndrome [5]. To date, the etiology of this 
phenomenon has yet to be elucidated. Sarcoid 
reaction is thought to be triggered by cytokines 
derived from tumor cells or antigens expressed 
by tumor cells [6, 7]. It is theorized that a T-cell 
mediated immunological hypersensitivity reac-
tion to tumor cell antigens leads to granuloma 
formation [8]. These granulomatous reactions 
may occur within neoplasms or regional lymph 
nodes that are either affected or unaffected by 
tumor [1]. The frequency of such sarcoid reactions 
in carcinomas is 4.4% [9]. 
This raises unique challenges for pulmonary 
physicians, including false reassurance of benign 
disease when granulomatous inflammation is 
found on aspirates of pulmonary nodules, mas-
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ses, and lymph nodes. Recently, endobronchial 
ultrasound transbronchial needle aspiration 
(EBUS-TBNA) has more frequently been em-
ployed for the sampling of mediastinal and 
hilar lymph nodes in cancer staging or work up 
of thoracic lymphadenopathy. Three previous 
studies examining EBUS-TBNA have shown that 
the presence of granulomatous inflammation 
on needle aspiration and the diagnosis of mali-
gnancy is mutually exclusive [10–12]. However, 
multiple case reports have been published that 
have shown the coexistence of granuloma and 
malignancy in the same lymph node on EBUS-
-TBNA [13, 14].
Our goal is to examine the granulomatous 
reaction to carcinoma in patients who have 
undergone lung resection and determine the 
frequency of coexisting of granulomatous in-
flammation with malignancy in mediastinal or 
hilar lymph nodes. This bears significant clinical 
importance as it can affect the sampling time of 
a lymph node and overall EBUS-TBNA procedure 
duration.
Material and methods
This is a  retrospective study investigating 
the association between granulomatous inflam-
mation and underlying malignancy in patients 
who underwent lung resection. The study was 
approved by the institution review board at Saint 
Louis University Hospital (IRB protocol Number 
27539).We queried our electronic health record 
(EHR) for all patients admitted to Saint Louis 
University Hospital, a 356-bed tertiary univer-
sity-affiliated facility in the Midwestern United 
States, from August 1, 2012 to October 31, 2016, 
with a procedure code which included lobectomy 
or pneumonectomy.
A total of 66 patients had undergone those 
procedures during the study period. Exclusion 
criteria were the following: (1) Resection was 
not completed; (2) Pathology data not available 
in EHR; or (3) Pathology negative for malignancy; 
(4) Pathology showing metastatic malignancy to 
the lung. Forty patients met criteria for inclusion 
in the study.
We collected data including age, gender, date 
of procedure, type of lung resection, the presence 
and location of granulomatous inflammation, 
existence of known granulomatous disease, pre-
sence of known fungal or mycobacterial infection, 
and when pertinent, pathologic stage of under-
lying malignancy according to the TNM staging 
system (seventh edition). 
Results
Baseline demographics of the sample is shown 
in Table 1. Mean age of the study subjects was 64.82 
years (range 30–80 years). Twenty seven (67.5%) 
patients were male, 2 (5%) were Hispanic. Twenty 
five (62.5%) subjects had upper lobes distribution 
of malignancy with 12 (30%) in the right upper 
lobe, 21 (52.5%) patients were diagnosed with 
adenocarcinoma while 14 (35%) and 4 (10%) with 
squamous cell and small cell histology, respecti-
vely. Thirty six (90%) individuals were current or 
former smokers, 2 (5%) and 1 (2.5%) patients had 
history of latent tuberculosis and connective tissue 
disease, respectively. None of the subjects were 
diagnosed with sarcoidosis in the past.
There were 35 (87.5%) patients that under-
went lobectomy while 5 (12.5%) subjects under-
went pneumonectomy. Of those 40 patients, 
3 (7.5%) had evidence of granulomatous inflamma-
tion in mediastinal or hilar lymph nodes (Table 2). 
None of these 3 individuals had evidence of ma-
Table 1. Demographics
n = 40 %
Age Mean 64.82
Range 30-80
Sex Male 27 67.5
Female 13 32.5
Race Non Hispanic 38 95
Hispanic 2 5




Diagnosis Adeno 21 52.5
Small cell 4 10
Squamous cell cancer 14 35































History of fungal/ 
/mycobacterial disease
60 F Lobectomy RUL LN 4, 10 NSCLC T2aN0M0 No No
60 M Lobectomy RUL LN 2 NSCLC T1aN0M0 No No
67 M Lobectomy LUL Mediastinal LN NSCLC T2aN0Mx No No
lignancy in the lymph node with granulomatous 
inflammation.
Discussion
Granulomatous inflammation in the lymph 
nodes has been described in various malignan-
cies. Granulomatous inflammation like sarco-
idosis can also present as PET avid masses and 
lymphadenopathy. The significance of granulo-
matous inflammation found during EBUS TBNA 
rapid on site cytological exam has not been well 
studied in patients with suspected primary lung 
malignancies. Our study aimed to identify the 
concurrence of granulomatous inflammation and 
malignancy in patients who underwent lobecto-
my or pneumonectomy for early stage lung cancer. 
In 1972, Brincker et. al. [4] reported granu-
lomatous inflammation with underlying lympho-
ma in less than 1% of lymphomas. Various case 
reports have described concurrence of diverse 
cancers and granulomatous inflammation around 
the cancer tissue. Steinfort et al. [12] examined 
187 patients who underwent mediastinoscopy, 
lobectomy or pneumonectomy. Eight out of 187 
(4.3%) had evidence of granulomatous inflamma-
tion in one of the sampled lymph node. However, 
none of these 8 patients had concurrent presence 
of malignancy and granulomatous reaction in 
the same lymph node. Kamiyoshihara et al. [15] 
reviewed 326 patients who underwent lobectomy. 
Granulomatous reaction was noted in 4 (1.2%) pa-
tients. None of these individuals had malignancy 
and granulomatous inflammation present in the 
same lymph node.
Tomimaru et al. [16] studied 1733 patients 
undergoing surgical treatment for lung cancer 
between 1990–2004. Twenty two (1.3%) subjects 
had granulomatous reaction in the resected lymph 
nodes. However, 4 out of 22 (18.2%) individuals 
with granulomatous inflammation had concurrent 
malignancy in the same lymph node. Similarly, 
Jepsen et al. [17] examined 630 patients who 
underwent surgical resection of lymph node for 
lung cancer. Twenty (3.2%) patients had granu-
lomatous reaction in the sampled lymph node. 
However, 2 out of 20 (10%) subjects with granu-
lomatous inflammation in the lymph node had 
concurrent malignancy. Jepsen et al. [17] also 
noticed that squamous cell carcinoma histology 
was more likely to be associated with granuloma-
tous inflammation in the lymph node. Bellinger 
et al. [18] examined 37 patients with extrathoracic 
malignancy and granulomatous inflammation in 
EBUS TBNA samples. On subsequent follow-up 
of the study subjects with surgical histology or 
radiography, it was determined that 2 (5.4%) 
patients had false negative lymph node EBUS 
TBNA. Comparatively, our cohort revealed that 
in none of our patients the coexistence of granu-
lomatous inflammation with malignancy in the 
resected lymph nodes occurred. 
The significance of granulomatous lympha-
denopathy in primary lung cancer is unclear. 
Steinfort et al. [19] examined 157 patients who 
underwent lobectomy. Eight subjects with gra-
nulomatous reaction in the lymph node were 
compared with 16 matched control patients. All 
of them were pN0 at baseline. Disease recurrence 
was noted in 7 control individuals compared to 
none of the cases. The author concluded that 
sarcoidal reaction in the lymph node may predict 
lower rate of disease recurrence after resection. 
Grosu et al. [20] compared 44 patients with gra-
nulomatous inflammation with 62 subjects with 
benign mediastinal adenopathy. Both groups had 
history of lung cancer and had no active mali-
gnancy at the beginning of the study.
The presence of granulomatous inflammation 
did not confer survival benefit as compared to the 
absence of granulomatous inflammation — 3-year 
survival was 93% vs. 88%, respectively (p = 0.4) 
[20]. Similarly, Kamiyoshihara et al. [15] did not 
find any significant difference in survival between 
the sarcoid group and control group.
The impact of these findings on clinical 
practice is substantial. EBUS time varies in diffe-
rent studies basing on the number of passes and 
the number of lymph nodes that are aspirated. 
Yasufuku et al. [21] examined the sensitivity 
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of EBUS-TBNA in 102 patients. In his study, 
mean EBUS TBNA time was 14.9 minutes (4–29 
minutes). Chrissian et al. [22] reported mean 
procedure time of 51 minutes in a  fellowship 
environment when procedures were done under 
moderate sedation using propofol. Lee et al. [23] 
studied the number of aspirations required to 
obtain optimal results with EBUS TBNA. In 
the study, an average of 1.6 lymph nodes were 
sampled per procedure  with an average of 4 
passes per a lymph node. The mean time for the 
EBUS ranged from 21.6 minutes for one lymph 
node station to 60.3 minutes for 3 lymph node 
stations, with a reported average time of 33.4 mi-
nutes. Additionally, Lee et al. [23] suggested that 
procedure time would be shorter if fewer passes 
were done per a lymph node station. Basing on 
our study, if granuloma is found during Rapid 
On Site Evaluation, it can be safely concluded 
that the nodal enlargement is unlikely secondary 
to malignancy and further lymph node sampling 
can be avoided, thus reducing overall procedure 
time and sedation medication doses.
One of the major limitation of our study 
is a small sample size. Additionally, the study 
was performed at single academic center in the 
Midwestern United States, which limits its ge-
neralizability. 
Conclusion
EBUS-TBNA is widely regarded as a type of 
a  staging tool in lung cancer. Previous studies 
have shown that the presence of granulomatous 
inflammation on EBUS-TBNA and the diagnosis 
of malignancy are mutually exclusive [10–12]. 
However, multiple case reports demonstrate 
a significant correlation between coexisting gra-
nulomatous inflammation in the lymph nodes 
on EBUS-TBNA. Our single-center retrospective 
study revealed a significantly higher incidence of 
(7%) of granulomatous inflammation in resected 
lymph nodes. But granulomatous inflammation 
was not associated with the presence of malignan-
cy in resected lymph node in patients undergoing 
lobectomy and pneumonectomy. We believe fur-
ther, larger, multicentered studies are needed to 
determine the true incidence and associated risk 
factors of concomitant granulomatous inflamma-
tion and malignancy.
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